Next to the above-discussed genomic aberrations, C5/MCD lymphomas frequently display CDKN2A deletions, which through its gene products p16 and p19 controls the RB1 and TP53 pathways, respectively (2, 28). Here, CDKN2A is linked to lymphoma.